AFFY
Price:
$0.0011
Market Cap:
$41.24K
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Industry
Biotechnology
IPO Date
2006-12-15
Stock Exchange
OTC
Ticker
AFFY
According to Affymax, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.71. This represents a change of -87.58% compared to the average of 5.74 of the last 4 quarters.
The mean historical Current Ratio of Affymax, Inc. over the last ten years is 5.84. The current 0.71 Current Ratio has changed 1.12% with respect to the historical average. Over the past ten years (40 quarters), AFFY's Current Ratio was at its highest in in the September 2006 quarter at 21.42. The Current Ratio was at its lowest in in the September 2004 quarter at 0.
Average
5.84
Median
2.79
Minimum
0.71
Maximum
20.10
Discovering the peaks and valleys of Affymax, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 20.10
Minimum Annual Increase = -82.60%
Minimum Annual Current Ratio = 0.71
| Year | Current Ratio | Change |
|---|---|---|
| 2013 | 0.71 | -31.12% |
| 2012 | 1.03 | -81.00% |
| 2011 | 5.44 | 160.45% |
| 2010 | 2.09 | 46.56% |
| 2009 | 1.43 | 4.78% |
| 2008 | 1.36 | -61.08% |
| 2007 | 3.50 | -82.60% |
| 2006 | 20.10 | 84.38% |
| 2005 | 10.90 | -7.68% |
| 2004 | 11.81 | Infinity% |
The current Current Ratio of Affymax, Inc. (AFFY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.40
5-year avg
2.14
10-year avg
5.84
Affymax, Inc.’s Current Ratio is less than Itoco Inc. (0.85), greater than Endonovo Therapeutics, Inc. (0.00), greater than Amarantus BioScience Holdings, Inc. (0.00), greater than Baseline Productions, Inc. (0.15), greater than Naturally Splendid Enterprises Ltd. (0.48), greater than CNBX Pharmaceuticals Inc. (0.01), greater than GeneLink, Inc. (0.42), less than West Island Brands Inc. (1.03), less than Veritas Farms, Inc. (1.12), less than ONE Bio Corp. (1.48),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.85 | $34.10K | |
| 0.00 | $31.88K | |
| 0.00 | $36.84K | |
| 0.15 | $37.19K | |
| 0.48 | $881.66K | |
| 0.01 | $37.01K | |
| 0.42 | $10.60K | |
| 1.03 | $60.06K | |
| 1.12 | $16.39K | |
| 1.48 | $1.69K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Affymax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Affymax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Affymax, Inc.'s Current Ratio?
How is the Current Ratio calculated for Affymax, Inc. (AFFY)?
What is the highest Current Ratio for Affymax, Inc. (AFFY)?
What is the 3-year average Current Ratio for Affymax, Inc. (AFFY)?
What is the 5-year average Current Ratio for Affymax, Inc. (AFFY)?
How does the current Current Ratio for Affymax, Inc. (AFFY) compare to its historical average?